In summary, the results highlighted the possibility of dual apoptotic and pro-survival responses in KRAS/PIK3CA-mutant CRC cells responding under hypoxic conditions with augmented inhibition of viability to the addition of ABT-737 to AZD8055. The gene discussed is KRAS; the disease is colorectal carcinoma.